Zikhron-Yaakov, Israel

Tomer Bronshtein

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tomer Bronshtein: Innovator in Liposomal Compositions

Introduction

Tomer Bronshtein is a notable inventor based in Zikhron-Yaakov, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work with liposomes. With a total of 4 patents to his name, Bronshtein's research has the potential to impact various medical applications.

Latest Patents

Among his latest patents, Bronshtein has developed compositions comprising liposomes made from whole cell membrane fractions. These liposomes can encapsulate or be attached to pharmaceutical agents, enhancing their delivery and efficacy. His work provides methods for generating and utilizing these liposomal compositions, which could lead to advancements in drug delivery systems.

Career Highlights

Tomer Bronshtein is associated with the Technion Research & Development Foundation Limited, where he continues to push the boundaries of innovation in pharmaceutical research. His expertise in liposomal technology positions him as a key figure in the development of new therapeutic strategies.

Collaborations

Bronshtein collaborates with Marcelle Machluf, a fellow researcher, to further explore the applications of liposomal compositions in medicine. Their combined efforts aim to enhance the effectiveness of pharmaceutical agents through innovative delivery methods.

Conclusion

Tomer Bronshtein's work in liposomal compositions exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His contributions are paving the way for new advancements in drug delivery systems, showcasing the importance of research and development in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…